NCT01353274已完成不适用
Survey on Drug Use of Micamlo Combination Tablets AP in Patients With Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,157
- 试验地点
- 254
- 主要终点
- Incidence of Drug-related Adverse Events
研究概览
简要总结
Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Patients with hypertension
干预措施: Micamlo (Drug)
结局指标
主要结局
Incidence of Drug-related Adverse Events
时间窗: 12 months
Number of patients with drug-related adverse events
次要结局
- Proportion of Patients Who Achieved the Target BP(after 1, 2, 3, 6, 12 months)
- Change From Baseline in Systolic Blood Pressure (SBP)(after 1, 2, 3, 6, 12 months)
- Change From Baseline in Diastolic Blood Pressure (DBP)(after 1, 2, 3, 6, 12 months)
- Proportion of Patients Who Normalised Their BP(after 1, 2, 3, 6, 12 months)
研究者
研究点 (254)
Loading locations...
相似试验
已完成
不适用
To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With HypertensionHypertensionNCT03021265Boehringer Ingelheim676
已完成
不适用
Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT02024971Takeda1,103
撤回
3 期
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient InsomniaTransient InsomniaNCT03338764Sequential Medicine Ltd
已完成
不适用
Drug Use-Results Survey on Picoprep® Combination PowderBowel CleansingNCT03631446Ferring Pharmaceuticals1,298
已完成
不适用
Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"Type 2 Diabetes MellitusNCT02003014Takeda899